Gender characteristics of the prevalence of noncommunicable diseases in the adult population of the Vladimir region
https://doi.org/10.15829/1728-8800-2023-3779
EDN: IMDQAE
Abstract
Aim. To assess the prevalence of major noncommunicable diseases (NCDs) taking into account gender characteristics in a random sample of adults in 5 cities of the Vladimir region.
Material and methods. This cross-sectional population-based study (May 2018 — March 2020) included 1350 people (men and women aged 30-69 years) from 5 cities of the Vladimir region. The response rate was 87%. A total of 1174 people completed the study. Of these, 424 (36,1%) were men and 750 (63,9%) women. Respondents were surveyed using a standard questionnaire prepared by the National Medical Research Center for Therapy and Preventive Medicine, which included socio-demographic characteristics, behavioral risk factors, data on somatic diseases and medications taken.
Results. The prevalence of coronary artery disease among men was 14,1%, among women — 9,5% (p=0,016). In men, the second most common disease is chronic obstructive pulmonary disease (COPD), which was 2,5 times more common than in women — 10,6 and 4,5%, respectively (p=0,001). Among women, the second most common disease was type 2 diabetes (T2D), accounting for 7,6%. Cerebrovascular diseases occupy fourth place in the NCD structure. Their prevalence was 6,1% among men and 4,4% among women. Cancer diseases were less common than other chronic diseases without sex differences — 2,8 and 3,1%, respectively. In certain cities, the prevalence of NCDs varied. Every third man and fourth women had a positive family history for cardiovascular diseases (CVDs) (p=0,005). About 20% of men reported a positive family history for COPD, while among women this figure was 2 times lower (p=0,001). Men and women were comparable in terms a family history for T2D — 10,4 and 12,5%, respectively. A positive family history for tumors of various locations was recorded in ~5%.
Conclusion. In the adult working-age population of the Vladimir region, atherosclerosis-related CVDs was identified in 17% of cases. The incidence of T2D and COPD in the adult population was approximately the same and amounted to >7%. The prevalence of cancer was 3%. Sex differences were identified in the prevalence of coronary artery disease and COPD.
About the Authors
M. N. MamedovRussian Federation
L. T. Sushkova
Russian Federation
Vladimir
R. V. Isakov
Russian Federation
Vladimir
V. A. Kutsenko
Russian Federation
Moscow
O. A. Drapkina
Russian Federation
Moscow
References
1. Drapkina OM, Kontsevaya AV, Kalinina AM, et al. 2022 Prevention of chronic non-communicable diseases in the Russian Federation. National guidelines. Cardiovascular Therapy and Prevention. 2022;21(4):3235. (In Russ.) doi:10.15829/1728-8800-2022-3235.
2. Shalnova SA, Deev AD. Coronary heart disease in Russia: prevalence and treatment (according to clinical and epidemiological studies). Therapeutich archive. 2011;83(1):7-12. (In Russ.)
3. Boytsov SA, Zairatyants OV, Andreev EM, Samorodskaya IV. Comparison of coronary heart disease mortality in men and women age 50 years and older in Russia and USA. Russian Journal of Cardiology. 2017;(6):100–107. (In Russ.) doi:10.15829/1560-4071-2017-6-100-107.
4. Shalnova SA, Drapkina OM, Kutsenko VA, et al. on behalf of the participants of the ESSE-RF study. Myocardial infarction in the population of some Russian regions and its prognostic value. Russian Journal of Cardiology. 2022;27(6):4952. (In Russ.) doi:10.15829/1560-4071-2022-4952.
5. Tanashyan MM, Raskurazhev AA, Kornilova AA. Cerebrovascular diseases and personalized prevention. Profilakticheskaya medicina. 2021;24(2):76-81. (In Russ.) doi:10.17116/profmed20212402176.
6. Dedov II, Shestakova MV, Vikulova OK, et al. Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021. Diabetes mellitus. 2021;24(3):204-21. (In Russ.) doi:10.14341/DM12759.
7. Safiri S, Carson-Chahhoud K, Noori M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ. 2022;378:e069679. doi:10.1136/bmj-2021-069679.
8. Chuchalin AG, Khaltaev N, Antonov NS, et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J COPD. 2014;12:963-74. doi:10.2147/COPD.S67283.
9. Postnikova LB, Kostrov VA, Boldina MV, Zelyaeva NV. Prevalence of chronic obstructive pulmonary disease in a large industrial center (Nizhny Novgorod). Pulmonology. 2011;(2):5-8. (In Russ.) doi:10.18093/0869-0189-2011-02-5-8.
10. Kaprin AD, Starinsky VV, Shakhzadova AO. Malignant neoplasms in Russia in 2021 (morbidity and mortality). M.: MNIOI im. P. A. Herzen — branch of the Federal State Budgetary Institution "National Medical Research Center of Radiology" of the Ministry of Health of Russia. 2022. 252 p. (In Russ.) ISBN 978-585502-280-3.
What is already known about the subject?
- Despite a certain variability, noncommunicable diseases (NCDs) significantly contribute to events and mortality of the adult population.
- Assessing their prevalence makes it possible to develop effective treatment and prevention tactics.
What might this study add?
- In a working-age adult population, the prevalence of type 2 diabetes and chronic obstructive pulmonary disease was comparable and amounted >7%.
- Gender differences have been identified in the prevalence of coronary artery disease and chronic obstructive pulmonary disease due to the greater prevalence of these diseases among men compared to women.
- Variability in the prevalence of NCDs between certain cities was revealed.
- The study revealed that 60% of those examined had a positive family history for NCDs and their combinations.
Review
For citations:
Mamedov M.N., Sushkova L.T., Isakov R.V., Kutsenko V.A., Drapkina O.A. Gender characteristics of the prevalence of noncommunicable diseases in the adult population of the Vladimir region. Cardiovascular Therapy and Prevention. 2023;22(12):3779. (In Russ.) https://doi.org/10.15829/1728-8800-2023-3779. EDN: IMDQAE